MedTrace Logo

Evaluate Safety of Tramadol in the Management of Postoperative Pain Following Surgery

NCT03395808 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 251

Last updated 2021-03-09

Study results available
· View outcomes & findings →

Summary

The study evaluates the safety of IV tramadol managing post-operative pain following surgery.

Conditions

  • Pain Management

Interventions

DRUG

Tramadol

IV; 50 mg given at Hours 0, 2, 4, 8 and every 4 hours thereafter, for a total of up to 43 doses

Sponsors & Collaborators

  • Avenue Therapeutics, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-22
Primary Completion
2019-04-25
Completion
2019-05-06
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03395808 on ClinicalTrials.gov